Presentation is loading. Please wait.

Presentation is loading. Please wait.

Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind.

Similar presentations


Presentation on theme: "Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind."— Presentation transcript:

1 Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo- controlled study  Atul Sharma, G.K. Rath, S.P. Chaudhary, Alok Thakar, Bidhu Kalyan Mohanti, Sudhir Bahadur  European Journal of Cancer  Volume 48, Issue 6, Pages (April 2012) DOI: /j.ejca Copyright © 2011 Elsevier Ltd Terms and Conditions

2 Fig. 1 Patient disposition.
European Journal of Cancer  , DOI: ( /j.ejca ) Copyright © 2011 Elsevier Ltd Terms and Conditions

3 Fig. 2 Overall survival in months.
European Journal of Cancer  , DOI: ( /j.ejca ) Copyright © 2011 Elsevier Ltd Terms and Conditions


Download ppt "Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind."

Similar presentations


Ads by Google